Organon (OGN) Tops Q3 EPS by 23c

Organon (NYSE: OGN) reported Q3 EPS of $1.67, $0.23 better than the analyst estimate of $1.44. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.58 billion.

GUIDANCE:

Organon sees FY2021 revenue of $6.2-6.3 billion, versus the consensus of $6.28 billion.

For earnings history and earnings-related data on Organon (OGN) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c